1. Home
  2. DRCT vs ALZN Comparison

DRCT vs ALZN Comparison

Compare DRCT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$4.10

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

SELL

Current Price

$2.20

Market Cap

8.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DRCT
ALZN
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
8.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
DRCT
ALZN
Price
$4.10
$2.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$330.00
$28.00
AVG Volume (30 Days)
7.2M
94.4K
Earning Date
11-06-2025
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,369,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$25.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$1.69
52 Week High
$80.85
$10.84

Technical Indicators

Market Signals
Indicator
DRCT
ALZN
Relative Strength Index (RSI) 90.17 49.88
Support Level $1.58 $2.13
Resistance Level $2.98 $2.54
Average True Range (ATR) 0.44 0.15
MACD 0.29 0.01
Stochastic Oscillator 70.16 49.59

Price Performance

Historical Comparison
DRCT
ALZN

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: